HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Juan A Rey Selected Research
Juan A Rey Research Topics
Disease
37
Neoplasms (Cancer)
05/2021 - 03/2003
9
Meningioma (Meningiomas)
06/2015 - 01/2004
9
Glioma (Gliomas)
04/2015 - 01/2006
8
Glioblastoma (Glioblastoma Multiforme)
05/2021 - 03/2003
7
Brain Neoplasms (Brain Tumor)
05/2021 - 07/2003
7
Medulloblastoma
09/2016 - 05/2003
6
Astrocytoma (Pilocytic Astrocytoma)
02/2014 - 03/2003
6
Oligodendroglioma
08/2013 - 07/2003
6
Acoustic Neuroma (Acoustic Neurinoma)
03/2013 - 10/2007
5
Carcinogenesis
01/2018 - 03/2003
5
Neurilemmoma (Schwannoma)
05/2013 - 11/2003
4
Neoplasm Metastasis (Metastasis)
01/2018 - 07/2003
3
Neuroblastoma
01/2014 - 11/2010
2
Stomach Neoplasms (Stomach Cancer)
10/2019 - 01/2018
2
Carcinoma (Carcinomatosis)
03/2016 - 07/2003
2
Primitive Neuroectodermal Tumors (PNET)
06/2011 - 10/2010
2
Ependymoma
03/2004 - 07/2003
1
Major Depressive Disorder (Major Depressive Disorders)
01/2022
1
Infections
01/2018
1
Spontaneous Remission
01/2014
1
Ewing Sarcoma (Sarcoma, Ewing)
06/2011
1
Nervous System Neoplasms (Neoplasms, Nervous System)
04/2010
1
Deafness (Deaf Mutism)
10/2007
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2007
1
Pituitary Neoplasms (Pituitary Adenoma)
02/2006
1
Prolactinoma (Prolactinomas)
02/2006
1
Adenoma (Adenomas)
02/2006
1
Adenocarcinoma
10/2005
Drug/Important Bio-Agent (IBA)
10
Tumor Suppressor Protein p14ARF (p14ARF)
IBA
01/2012 - 03/2003
7
Proteins (Proteins, Gene)
FDA Link
04/2015 - 10/2005
6
Caspase 8 (Caspase-8)
IBA
02/2006 - 09/2003
5
Temozolomide (Temodar)
FDA Link
Generic
01/2021 - 06/2013
5
Biological Products
IBA
01/2018 - 10/2007
5
DNA (Deoxyribonucleic Acid)
IBA
03/2016 - 07/2003
5
Cyclin-Dependent Kinase Inhibitor p16
IBA
01/2012 - 04/2003
5
Tissue Inhibitor of Metalloproteinase-3
IBA
11/2004 - 03/2003
3
Cyclin D1
IBA
01/2011 - 10/2007
3
Complementary DNA (cDNA)
IBA
01/2010 - 02/2009
3
Death-Associated Protein Kinases
IBA
01/2004 - 04/2003
2
Panobinostat
IBA
01/2021 - 01/2020
2
RNA (Ribonucleic Acid)
IBA
10/2019 - 01/2010
2
Pharmaceutical Preparations
IBA
01/2018 - 12/2014
2
Small Interfering RNA (siRNA)
IBA
01/2018 - 11/2010
2
Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))
IBA
03/2015 - 08/2013
2
lomeguatrib
IBA
02/2014 - 06/2013
2
Neurofibromin 2 (Merlin)
IBA
03/2013 - 10/2005
2
gamma Catenin (Plakoglobin)
IBA
02/2011 - 11/2010
2
Cyclin D2
IBA
02/2011 - 11/2010
2
Epidermal Growth Factor (EGF)
IBA
04/2010 - 10/2009
2
Glutathione Transferase (Glutathione S-Transferase)
IBA
01/2004 - 04/2003
1
Biomarkers (Surrogate Marker)
IBA
01/2022
1
Telomerase (Telomerase Reverse Transcriptase)
IBA
01/2022
1
Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)
IBA
01/2022
1
Cadherins (E-Cadherin)
IBA
05/2021
1
Protein Isoforms (Isoforms)
IBA
05/2021
1
Histone Deacetylase 6
IBA
05/2021
1
eprenetapopt
IBA
01/2021
1
Histone Deacetylase Inhibitors
IBA
01/2020
1
Histones (Histone)
IBA
05/2019
1
Enzymes
IBA
05/2019
1
Ubiquitin
IBA
01/2018
1
Peptides (Polypeptides)
IBA
10/2016
1
Transforming Growth Factor beta (TGF-beta)
IBA
10/2016
1
Suspensions
IBA
09/2016
1
Laminin (Merosin)
IBA
09/2016
1
X-linked Nuclear Protein
IBA
03/2015
1
Culture Media
IBA
01/2014
1
2-toluenesulfonamide (OTS)
IBA
08/2013
1
Neurofibromin 1 (Neurofibromin)
IBA
07/2013
1
Caveolin 1
IBA
03/2013
1
Neuregulin-1 (Neuregulin 1)
IBA
03/2013
1
Osteopontin
IBA
03/2013
1
Androgen Receptors (Androgen Receptor)
IBA
03/2013
1
Messenger RNA (mRNA)
IBA
03/2013
1
Integrins
IBA
03/2013
1
MicroRNAs (MicroRNA)
IBA
01/2013
1
arginylarginine (Arg-Arg)
IBA
10/2012
1
arginylproline
IBA
10/2012
1
prolyl-proline (Pro-Pro)
IBA
10/2012
1
Transforming Growth Factors (Transforming Growth Factor)
IBA
10/2012
1
Stem Cell Factor
IBA
06/2011
1
Imatinib Mesylate (Gleevec)
FDA Link
06/2011
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
06/2011
1
Patched-1 Receptor
IBA
02/2011
1
WD repeat containing planar cell polarity effector
IBA
02/2011
1
Catenins
IBA
02/2011
1
Zinc Finger Protein GLI1
IBA
02/2011
1
Carcinogens
IBA
01/2011
1
cyclopamine
IBA
10/2010
1
Complement System Proteins (Complement)
IBA
04/2009
1
Cyclins
IBA
10/2007
1
ErbB Receptors (EGF Receptor)
IBA
02/2007
1
Gefitinib (Iressa)
FDA Link
02/2007
1
Thyrotropin (Thyroid-Stimulating Hormone)
FDA Link
02/2006
1
Growth Hormone (Somatotropin)
IBA
02/2006
Therapy/Procedure
7
Therapeutics
05/2021 - 11/2010
6
Drug Therapy (Chemotherapy)
01/2021 - 04/2009
5
Ligation
01/2014 - 01/2007
2
Aftercare (After-Treatment)
01/2022 - 10/2010
2
Radiotherapy
01/2021 - 01/2020